An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model.

Cancer Immunol Res 2019 02 4;7(2):219-229. Epub 2018 Dec 4.

Aging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.

Natural killer (NK) cells are primary immune cells that target cancer cells and can be used as a therapeutic agent against pancreatic cancer. Despite the usefulness of NK cells, NK-cell therapy is limited by tumor cell inhibition of NK-cell homing to tumor sites, thereby preventing a sustained antitumor immune response. One approach to successful cancer immunotherapy is to increase trafficking of NK cells to tumor tissues. Here, we developed an antibody-based NK-cell-homing protein, named NK-cell-recruiting protein-conjugated antibody (NRP-body). The effect of NRP-body on infiltration of NK cells into primary and metastatic pancreatic cancer was evaluated and in murine pancreatic ductal adenocarcinoma models. The NRP-body increased NK-cell infiltration of tumors along a CXCL16 gradient (CXCL16 is cleaved from the NRP-body by furin expressed on the surface of pancreatic cancer cells). CXCL16 induced NK-cell infiltration by activating RhoA via the ERK signaling cascade. Administration of the NRP-body to pancreatic cancer model mice increased tumor tissue infiltration of transferred NK cells and reduced the tumor burden compared with that in controls. Overall survival of NRP-body-treated mice (even the metastasis models) was higher than that of mice receiving NK cells alone. In conclusion, increasing NK-cell infiltration into tumor tissues improved response to this cancer immunotherapy. The combination of an NRP-body with NK-cell therapy might be useful for treating pancreatic cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0317DOI Listing
February 2019
3 Reads

Publication Analysis

Top Keywords

pancreatic cancer
24
nk-cell infiltration
12
nk-cell therapy
12
cells
9
cancer
9
cancer cells
8
tumor tissues
8
cancer immunotherapy
8
cells primary
8
pancreatic
7
nk-cell
7
tumor
6
nrp-body
6
infiltration
5
gradient cxcl16
4
cxcl16 gradient
4
activating rhoa
4
infiltration tumors
4
cxcl16 cleaved
4
tumors cxcl16
4

Similar Publications